Needham Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $71

Futu News00:32 · Ratings

Immunocore Holdings Positioned for Growth With Strategic 2025 Priorities and Strong Financial Outlook

TipRanksJan 10 23:35

Immunocore Reports Cash, Equivalents of $820M as of December 31

Seeking AlphaJan 10 21:04

Cancer Immunotherapy Global Market Overview 2023-2030, Competitive Analysis of Amgen, AstraZeneca,Bayer, BMS, Eli Lilly, F. Hoffmann-La Roche, GSK, Immunocore, J&J, Merck, Novartis, Pfizer

Yahoo FinanceJan 10 17:06

Immunocore to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswireJan 6 20:00

Immunocore Names Non-Executive Board Member as CFO

WSJJan 2 20:34